Washington Examiner
Sign in Subscribe
News
Politics
White House
Senate
House
Campaigns
Business
World
Investigations
Justice
Supreme Court
Crime
Entertainment
Washington Secrets
Policy
Defense
National Security
Energy and Environment
Education
Immigration
Finance and Economy
Healthcare
Foreign Policy
Tech
Infrastructure
Space
2026 Election
America at 250
IN FOCUS
Commentary
Columnists
Editorials
Think Tanks
Beltway Confidential
Op-Eds
Restoring America
Patriotism and Unity
Faith, Freedom, and Self-Reliance
Courage, Strength, and Optimism
Equality, Not Elitism
Community and Family
Fairness and Justice
Mission
Watch
Magazine
Magazine
Quarterly Briefing
Archives
Games
Sponsored
Protecting Air Ambulance Services
Powering Progress
ASAE – Association Leadership
National Parks
Examining Tax Reform
Fix TSCA
Inside the Corn Belt
Examining Transportation
Newsletters
Sign In Sign InHome
News
Politics
Policy2026 Election
Opinion
EditorialsOp-Eds
In FocusRestoring AmericaMagazineWatch
Sponsored
Protecting Air Ambulance ServicesPowering ProgressASAE – Association LeadershipNational ParksExamining Tax ReformFix TSCAInside the Corn BeltExamining Transportation
TWS Archive
Advertisement
Home › Authors › Posts by Matthew Perrone

Matthew Perrone

Read the latest stories and analysis from Matthew Perrone.

Business

FDA: little evidence to drop Chantix boxed warning

Matthew Perrone · October 14, 2014 10:57 pm
Business

New once-a-day pill for hepatitis C wins FDA OK

Matthew Perrone · October 10, 2014 9:16 pm
Business

Safety advocates seek stronger warnings on Chantix

Matthew Perrone · October 8, 2014 8:27 pm
FILE - In this July 5, 2008 file photo, a farmer holds Monsanto Soy Bean seeds at his family farm in Bunceton, Mo. Monsanto Company reports quarterly financial results on Wednesday, Oct. 8, 2014. (AP Photo/Dan Gill, File) Business

Monsanto posts larger-than-expected 4Q loss

Matthew Perrone · October 8, 2014 3:38 pm
Business

Experimental drug provided to Dallas Ebola patient

Matthew Perrone · October 6, 2014 8:04 pm
Business

Drugmaker submits harder-to-abuse Zohydro to FDA

Matthew Perrone · October 1, 2014 6:33 pm
Business

New FDA label bolsters safety case for Chantix

Matthew Perrone · September 24, 2014 9:40 pm
FILE - FDA Commissioner Dr. Margaret A. Hamburg poses for a portrait before a newsmaker interview at the Associated Press in Washington, in this May 30, 2014 file photo. In a letter released Wednesday, Sept. 24, 2014 anti-addiction activists are calling for the Food and Drug Administration's top official to step down, saying the agency's policies have contributed to a national epidemic of prescription painkiller abuse.  (AP Photo/J. David Ake, File) Business

Anti-addiction groups call for new FDA chief

Matthew Perrone · September 24, 2014 5:56 pm
Business

FDA warns doctors to beware fake drug distributors

Matthew Perrone · September 23, 2014 2:24 pm
News

Experts want restrictions on testosterone drug use

Matthew Perrone · September 17, 2014 9:46 pm
Business

Big cities take aim at prescription painkillers

Matthew Perrone · September 16, 2014 5:25 pm
Business

FDA approves weight-loss drug Contrave

Matthew Perrone · September 11, 2014 5:48 pm
Advertisement
  • 1
  • 2
  • 3
  • …
  • 13
  • ›Next page
Page 1 of 13
Advertisement
Washington Examiner Manage Preferences

News

  • Politics
    • White House
    • Senate
    • House
    • Campaigns
  • Business
  • World
  • Investigations
  • Justice
  • Supreme Court
  • Crime
  • Washington Secrets
  • Entertainment
  • Sports

Policy

  • Defense
  • National Security
  • Energy
  • Immigration
  • Finance and Economy
  • Healthcare
  • Foreign Policy
  • Tech
  • Infrastructure
  • Space

Commentary

  • Columnists
  • Editorials
  • Think Tanks
  • Beltway Confidential
  • Op-Eds

Restoring America

  • Patriotism & Unity
  • Faith, Freedom & Self-Reliance
  • Courage, Strength & Optimism
  • Equality, Not Elitism
  • Community & Family
  • Fairness & Justice
  • Mission

Watch

  • Shows
NEWSLETTERS MAGAZINE ARCHIVE
  • Policies and Standards
  • Terms Of Service
  • Subscription Terms of Use
  • Privacy Policy
  • Your Privacy Choices
  • Transparency In Coverage
  • Advertise
  • Subscribe
  • Contact
  • Careers
  • Staff
  • About Examiner
  • Facebook
  • Twitter
© Copyright 2026. Washington Examiner. All Rights Reserved.
Advertisement